Writing An Analytical Essay

First, scald the fruit, then rub the pulp through a thick hairsieve made for the writing an analytical essay purpose, called a pulping sieve. You may do it for aneed with the back of a spoon. Then take this pulp thus drawn, and addto it its weight of sugar, and no more. Put it into a pewter vessel, and over a charcoal fire. Stir it up and down till the sugar be melted, and your conserve is made 4 thus you have the way of making conserves. The way of keeping themis in earthen pots 5 the dose is usually the quantity of a nutmeg at a time morning andevening, or unless they are purging when you please 6 of conserves, essay keep thesis years, as conserves of roses. Othersbut a year, as conserves of borage, bugloss, cowslips and the like 7 have a care of the working of essay conserves presently after theyare made. Look to them once a day, and stir them about.

The spirocheticidal value of disodium ethylarsenate writing an analytical essay mon-arsone, j a m a 76. 1335 may 14 1921 oxyl-iodide not admitted to n n r report of the council on pharmacy and chemistry“oxyl-iodide” eli lilly and co is said to be the hydroiodid ofcinchophen and the claim is made that it exerts the effects ofcinchophen and of iodid because of inquiries which have been receivedthe council decided to determine the eligibility of “oxyl-iodide” fornew and nonofficial remedies dr p j hanzlik-- formerly associateprofessor of pharmacology at western reserve university school ofmedicine, now professor of pharmacology at leland stanford junioruniversity medical school-- who has made a study of the action ofsalicylates and cinchophen, was asked to report on the therapeuticvalue and the rationality of “oxyl-iodide ” this he consented to do andhis report appears below after considering doctor hanzlik report, the council declared“oxyl-iodide” inadmissible to new and nonofficial remedies because itis an irrational combination, marketed under claims that are unprovedand consequently unwarranted w a puckner, secretary “oxyl-iodide, ” marketed by eli lilly & co , is claimed to be thehydroiodid of phenylcinchoninic acid, containing 33 per cent of iodinand 67 per cent of phenylcinchoninic acid cinchophen its solubilityresembles that of cinchophen, being low in water and acid mediums, andhigher in the presence of alkalis whether “oxyl-iodide” is decomposedinto its constituents in the presence of alkalis does not appear tohave been determined however, if this were the case, the intestine, after administration of “oxyl-iodide, ” would contain cinchophen andsodium iodid in the same forms as if these agents were administeredindividually so that nothing would be gained by administering“oxyl-iodide ” being, like cinchophen, practically insoluble in acidmediums, “oxyl-iodide” would have no advantage over the latter so faras gastric irritation is concerned dosagethe dosage advised is from one to three tablets containing 3 grains 0 2 gm each of “oxyl-iodide ” the total dosage would depend onthe condition to be treated in rheumatic fever, which requires afull therapeutic or so-called, “toxic” dose of cinchophen, about 12to 13 gm would be administered intensively since each tablet of“oxyl-iodide” contains 0 13 gm of cinchophen, the total number oftablets of “oxyl-iodide” required would be 100, or two and one-halfbottles of forty tablets each at the same time the patient wouldreceive 6 6 gm of iodin as iodid this might be distinctlyobjectionable because of the production of the disagreeable symptoms ofiodism in essay persons, and indicates that the fixed proportion of theiodin constituent would be objectionable even a smaller dosage, such as 5 gm of cinchophen, which gives writingialrelief in rheumatism and similar conditions, would still require apatient to take a full bottle, or forty tablets, of “oxyl-iodide, ” andat the same time about 2 7 gm of iodin would have to be ingested furthermore, rheumatic fever, the arthritides, gout and relatedconditions in which cinchophen is indicated do not require iodid therefore, “oxyl-iodide” would not be the remedy of choice in theseconditions, and its use would be irrational and illogical actionsno data on the pharmacologic actions of “oxyl-iodide” are presentedin the manufacturer literature presumably, the compound wouldexhibit the actions of its individual components, i e , cinchophen andiodin as iodid, though probably less efficiently, owing to its lowsolubility this is also indicated by the following statements of themanufacturer. “the analgesic action of ‘oxyl-iodide’ is gradual a wordof caution is necessary to those who may expect immediate relief frompain ” therefore, why use “oxyl-iodide” in place of more dependableanalgesics, such as salicylate or cinchophen the following statementsappear far-fetched. “there is a stimulation of the endocrines whichis perhaps more marked in the thyroid gland, although it is probablyshared by the pituitary and other glands which function in a chain-likecontrol there is stimulation of cells with increased flow ofsecretion, visibly demonstrated by the nasal mucous membrane after‘oxyl-iodide’ has been taken for essay time the general action onmucous membranes favors elimination of toxins and waste products ”it is probable that “oxyl-iodide” acts as a uric acid eliminant, thoughthere is no reason to suppose that it is more effective than cinchophenalone no data are given for this in the manufacturer literature usessuccessful use of “oxyl-iodide” is claimed in brachial and sciaticneuritis, lumbago, muscular rheumatism, arthritis deformans, chronicarthritis “ in essay instances were apparently cured”, subacutebronchitis, circumflex neuritis, traumatic orchitis, eczema andrheumatism however, a careful reading of the protocols of seven paper, representing these conditions, gives an unfavorable impression as tothe real contribution to the recovery by, or value received from, “oxyl-iodide ” summarized, the opinions as quoted by the manufacturersin support of their claims for “oxyl-iodide” are briefly as follows:case 1 “of course, the case is not complete yet, but i am looking forcontinued betterment ”case 2 “for two weeks past her improvement has been marvelous ”case 3 “the joints are still enlarged and we do not hope to clear thementirely ”case 4 “undoubtedly, removal of the kidney had much to do withimprovement ”case 5 “i think i have gotten very good results ”case 6 “essay apparent benefit ”case 7 “she is practically free from pain, and the muscle and jointstiffness is now slight ”these inconclusive opinions certainly do not agree with the favorableimpression which other portions of the manufacturer literaturecreate if the factor of natural recovery in the conditions representedby these seven paper is given due weight, little, if anything, isleft to the credit of “oxyl-iodide ” such clinical evidence as issupplied by the manufacturer indicates that the therapeutic efficiencyof “oxyl-iodide” is doubtful, and not an improvement over eithercinchophen or iodid iodismiodism cannot be avoided by the use of “oxyl-iodide, ” for themanufacturer literature states that “the dosage of ‘oxyl-iodide’may be pushed to iodism as manifested by skin symptoms to avoidiodism there should be an occasional interruption of treatment ”“oxyl-iodide, ” therefore, has no advantage over ordinary sodium iodidto avoid iodism usually, the conditions which require cinchophendo not require the simultaneous administration of iodids, and viceversa if administration of iodid and cinchophen together should beindicated or desirable, these can be given separately with the addedadvantage that the iodid can be easily reduced or withdrawn in caseiodism supervenes, and the cinchophen could be continued if necessary since conditions do not arise frequently enough to warrant the useof iodid and cinchophen together, the existence of such a product as“oxyl-iodide” is unwarranted finally, the manufacturer himself recognizes that phenylcinchoninicacid cinchophen can take the place of “oxyl-iodide ” under“dosage, ” the circular states. “a few patients may be idiosyncraticto the iodides and find they cannot take ‘oxyl-iodide ’ for thelatter chloroxyl, the hydrochloride of phenylcinchoninic acid, isrecommended ” the action of the hydrochlorid of phenylcinchoninic aciddoes not differ, of course, from that of cinchophen the difficultiesof assigning a clear-cut, definite, therapeutic rôle to “oxyl-iodide”in order to justify its existence, alongside well-known and triedremedies are self-evident conclusion“oxyl-iodide” is pharmacologically and therapeutically an illogical, irrational and unjustified substitute for cinchophen and iodids theconditions which require the administration of cinchophen do not asa rule require the administration of iodid and vice versa if it isdesirable to secure the effects of iodid and cinchophen together, thesecan be more conveniently and advantageously administered as separateagents, permitting in that way a better control of their actions thiscannot be accomplished with “oxyl-iodide, ” in which the proportion ofiodid and cinchophen are fixed symptoms of iodism cannot be avoidedby the administration of “oxyl-iodide ” the objective evidences forits actions and uses are totally lacking. And the clinical opinionsconcerning its therapeutic benefits in different disease conditionsare inconclusive and hedging, and, if anything, contradictory to thefavorable impressions which the language of the advertising matter islikely to create -- from the journal a m a , july 2, 1921 quassia compound tablets report of the council on pharmacy and chemistrythe council has authorized publication of the following report, declaring that quassia compound tablets flint, eaton and company areinadmissible to new and nonofficial remedies w a puckner, secretary quassia compound tablets, marketed by flint, eaton and company, decatur, ill , according to the label on a trade package submitted tothe council, contain in each tablet. Quassia 3/4 grain aloin 1/4 grain chionanthus 1 grain ipecac 1/16 grain wahoo 3/4 grain podophyllin 1/4 grain nux vomica 1/2 grain gingerine q s cascara 1/3 grainin the advertising the “cascara” of the label is replaced by theindefinite term “cascarin” and the “gingerine q s ” by “carminativeantigripe q s ” flint, eaton and company informed the council that“carminative antigripe is c p sodium sulphite of which each tabletcontains 1/4 grain ” the tablets were treated with dilute hydrochloricacid and the odor of sulphur dioxid became apparent this shows thatthe company statement to the council, that the tablets contain asulphite, is correct and the formula on the label is incorrect in the advertising for this preparation we read.

“this is a judicious combination ofvegetable products combined in well balanced proportions withnon-irritating antiseptics , ” “it incorporates a sufficient quantityof mild antiseptics of the thymol class ” and “ contains noformaldehyde ”2 probably a simple tragacanth jelly, which can be made cheaply, willproduce the same effects as those of the proprietary preparation thefollowing formula was published by mr j k thum, apothecary at thegerman hospital, philadelphia druggists circular, september, 1915, p 586:lubricating jelly tragacanth, whole 3 gm glycerin 25 c c phenol 1 5 gm distilled water, a sufficient quantity to make 300 c c the tragacanth is broken in small pieces, and put into a wide-mouthed bottle. The other ingredients are added and the bottle frequently shaken in regard to this formula, mr thum writes. It has been used in our gynecologic dewritingment for years for the last six years we have been dispensing it in collapsible tubes throughout the hospital for general work -- correspondence in the journal a m a , may 12, 1917 “nikalgin” to the editor:-- collier has a special article this week on “nikalgin ” have you any information on this subject?. it sounds like nostrum stuff p r minahan, m d , fond du lac, wis answer -- “nikalgin” is said to be the “invention” of gordon edwards, anengineer large claims for its anesthetic and antiseptic virtues havebeen made while no very definite information seems to be forthcomingregarding the preparation, it has been said to be “composed of quinin, hydrochloric acid and urea ” this would indicate that “nikalgin” maybe nothing more wonderful than the well known local anesthetic, quininand urea hydrochlorid, the quininae et ureae hydrochloridum of theu s pharmacopeia, or a modification of it -- query in the journala m a , sept 22, 1917 pertussin and syrup of thyme to the editor:-- a short time ago i received a sample of “pertussin” and used essay in an obstinate case of bronchitis with excellent results i have since received a catalog from a pharmaceutical firm, which advertises syrup of thyme i have searched for a formula to make my own syrup of thyme, but have not been able to find one will you publish one?. e f benner, m d , salfordville, pa answer -- the subjoined formula yields a product very similar to“pertussin” in taste, flavor, composition, and probably in activity aswell. Fluidextract of thyme 15 c c glycerin 15 c c syrup to make 100 c c the original german preparation contained 1 5 gm of sodium bromidin each hundred cubic centimeters, and this might be added to theforegoing formula with advantage, so far as action is concerned however, a sample of “pertussin” purchased in the open market in theunited states failed to respond to tests for bromids as fluidextract of thyme is not official, this formula is presented asfurnishing an acceptable preparation. Thyme, in no 60 powder 100 gm moisten with a mixture of. Water 25 c c alcohol 15 c c glycerin 10 c c after standing five hours, pack in a percolator exhaust with amenstruum of alcohol, 1 volume, and water, 3 volumes reserve the first85 c c of percolate concentrate the weak percolate to a soft extractand dissolve in the reserved portion make up to 100 c c by additionof a mixture of alcohol, 1 volume, and water, 3 volumes other aromatic expectorants, such as terebene, terpin hydrate orcreosote, might be expected to have similar but greater effect inchronic bronchitis query in the journal, a m a , march 27, 1920 quinin and urea hydrochlorid to the editor:-- could you tell me why quinin and urea hydrochlorid has not become more popular for local anesthesia?. is it less efficacious or more toxic than other preparations?. if it is useful, can you name essay trustworthy firm or brand?.

Ifit is marketed under a name which is in any way protected, or ifits manufacturer claims for it any unusual therapeutic qualities proprietary mixtures which are marketed in conformity with therules are listed in the appendix of the book under the names of therespective manufacturers such proprietary mixtures are not admittedto the body of the book, save in the exceptional paper cited in thepreceding paragraph nonproprietary mixtures of official substances -- since the ingredientsof such mixtures do not require consideration by the council, andsince the mixtures are not open to the proprietary abuses which callfor the work of the council, it is not necessary that they should beinvestigated by the council the physician must judge whether suchmixtures should be directed to be prepared by the pharmacist, orwhether he is justified in ordering a ready-made preparation if hedecides to use a ready-made, nonproprietary preparation, he must judgefor himself whether it is marketed in accordance with the rules itshould, however, be remembered that the application of a trade name toany substance makes it proprietary explanation of rule 1. Compositionsecrecy objectionable -- it is not only the right but also the duty ofthe physician to know the essential composition of what he prescribes;the council cannot compromise on this proposition vehicles and preservatives -- in the case of mixtures, not only thepotent ingredient, but also the general character of the vehicle, thepresence of alcohol, and the identity of preservatives, or of any othersubstance, whether added or present as an impurity, must be stated ifthese can under any circumstances affect the therapeutic action ofthe article this, as a rule, does not mean the publication of tradesecrets, such as flavors or the details of the working formula trade secrets -- furthermore, trade secrets will not be received asconfidential by the council, since it accepts information only withthe distinct understanding that this may be freely published, at itsdiscretion inspection of factories -- the council does not accept invitations toinspect factories. Its concern is with the finished products on the other hand, the council requires that the information becomplete and accurate as to medicinal ingredients unofficial constituents -- unofficial constituents of proprietarymixtures must be presented by the manufacturer in the regular way andmust be acted on by the council before the preparations containing themcan be accepted fraud -- when it appears that a manufacturer has made a deliberatelyfalse statement concerning a product, he is asked to furnish anexplanation. And if this is not satisfactory, the product will not beaccepted, even if the false statement is subsequently corrected oromitted testimonials -- the foregoing paragraph applies not only to statementsmade to the council, but also to statements furnished to physicians bythe manufacturer or his agents, even when these statements are in theguise of testimonials explanation of rule 2. Identificationin order to avoid errors in the case of chemical compounds, and toguard against adulterations, lack of potency or strength, and themistaking of one chemical for another, it is necessary to have at handsuitable tests tests, etc -- if these facts have appeared in the literature, orin standard textbooks, reference to them will be sufficient. Butwith new chemicals, especially synthetics, the manufacturer or hisrepresentatives will be required to supply such tests for publication, as will assure an intelligent opinion of these products physiologic standardization -- in paper in which chemical methods ofidentification are unknown or unreliable, physiologic standardizationshould be employed the council considers the phrase “physiologicallystandardized” or “assayed” as misleading unless the standard andmethod are published in sufficient detail to permit of their controlby independent investigators it is evident that when no standard ispublished, it is impossible to know whether the quality is high orlow, and the conscientious manufacturer who sets for himself a highstandard is placed on a level with the dishonest or careless one whoadopts a low standard again, if the process of standardization isnot published, it is impossible to learn, without actual trial, therelative value of one preparation as compared with that of anothermanufacturer, or to confirm or disprove the statements of themanufacturer as to the quality of his product standardization of disinfectants and germicides -- no disinfectant orgermicide of the phenol type will be accepted for new and nonofficialremedies whose phenol coefficient, determined according to the methodof the hygienic laboratory, u s p h s , is not stated on the labelof the preparation explanation of rule 3. Direct advertisinglay advertising -- the impossibility of controlling the irresponsibleclaims which are usually made in advertisements to the public, thewell-known dangers of suggesting by descriptions of symptoms to theminds of the people that they are suffering from the thesis diseasesdescribed, the dangers of the unconscious and innocent formation of adrug habit, and the evils of harmful self-medication, including thedangers of the spread of thesis infectious and contagious diseases whenhidden from the physician, and similar well-known considerations, arethe reasons for discouraging, in the interest, and for the safety, ofthe public, this reprehensible form of exploitation advertising inmedical journals, etc , distributed solely to physicians, does not comewithin the scope of this rule exceptions -- in the case of subjects on which the public should beinstructed, as the use of disinfectants, germicides, antiseptics andfoods, advertisements to the public, if not in objectionable forms, are considered admissible in no case shall such advertisementsinclude recommendations for use as curative agents, nor shall thenames of any diseases be mentioned in exploitation if the preparationis sufficiently toxic to require caution in its use to preventpoisoning, this fact shall be stated on the label on account of thedeplorable results which would follow any abuse of this privilege, theconscientious cooperation of manufacturers and their agents in adheringstrictly to the limitations laid down is asked. And for the same reasonthe acceptance of an article which is so advertised as to infringe onthese limitations in any essential way as by naming diseases or bymaking false and exaggerated claims shall be summarily rescinded, and the reasons for such action may be published without notice tomanufacturer or agent a disinfectant, germicide or antiseptic willbe accepted for description in new and nonofficial remedies, and anarticle of this class which has already been accepted will continueto be included in new and nonofficial remedies only on the explicitunderstanding by the manufacturer and agent that such infringements ofthe rule will be followed by deletion of the article and by publicationof the facts as described foods -- we may divide the foods into three groups the first groupcontains the ordinary foods, including the well-known breakfastfoods these do not come under the supervision of the council inany way the second group includes a large and important class ofmanufactured products, such as invalid and infant foods, which in asense stand between the first and third groups the public has thesame interest in these foods that the physician has, and usually issupplied with full information concerning them while the primaryrecommendation of these articles should naturally come from thephysician, it cannot be expected that their continued use shoulddepend on repeated prescriptions information concerning this groupof foods would come naturally and properly from a physician, and thecollection and dissemination of this information may very properly beincluded in the work of this council as the products in this classare used extensively, it is not proper to limit their advertisingto medical journals, but the advertising should be permitted in thelay press so long as it is conducted in a manner compatible withthe rules of the council the third group includes medicinal foodsproper, such as predigested foods these have a relatively low foodvalue and are characterized by a high alcohol or preservativecontent they frequently contain strictly medicinal substances, orfood substances for which distinct therapeutic properties are claimed these products should be used only on the advice of the physician, andthe advertisements should be restricted as in the case of ordinarymedicines advertisements in foreign countries -- the council deals primarily, inthe interest of the public and of the medical profession, with articlesproposed for admission to new and nonofficial remedies, and, indetermining the status of any article, must take into consideration anystatements made regarding it or any method of advertising it employedby the manufacturer or his authorized agents or representatives, whether in this country or abroad the council will not regard aswithin its scope, however, questions concerning the marketing ofarticles except the matter of direct advertising to the laity andunwarranted claims or misrepresentations in any country which has apublic body corresponding to this council explanation of rule 4. Indirect advertisingmatter distributed solely to physicians -- it should be rememberedthat the sole intent of this rule is to protect the physician, sothat in prescribing a proprietary medicine he shall not unconsciouslyadvertise proprietary preparations the rule imposes no restriction onthe legitimate methods of bringing a remedy to the attention of theprofession, such as advertising in medical journals, circulars andother printed matter distributed solely to physicians the rule appliesonly to the package as it may reach the patient naming diseases on labels -- the naming of diseases on the labelor package is not necessary, as is shown by the very large numberof proprietary products which have been successfully introducedwithout resorting to this expedient this method of popularizing aproprietary remedy with the laity is most objectionable, and should notbe tolerated in any form in general, therapeutic indications shouldbe omitted from the label and package the council will not insiston this point, however, when such indications are so given as not topromote self-medication, writingicularly in diseases which require expertdiagnosis and supervision it will be considered an infringement ofthe rule if an article be marketed in bottles which have the name ofthe article blown into the glass, or if otherwise the name or initialsor other distinctive mark of the article is permanently stamped onthe container, on the article itself, or is on the stoppers or seals articles which are marketed in any of these ways are not acceptedfor new and nonofficial remedies readily removable labels are notobjectionable, nor is the permanent affixing of the firm initials orname to the trade package if such initials or name is not suggestive ofthe article the council does not countenance the use of an acceptedarticle for advertising other articles which have not been accepted bythe council explanation of rule 5. False claims as to originsource -- no false or misleading statement in regard to an article canbe permitted concerning the source of material from which it is made, or the persons by whom it is made essay glaring frauds of this naturehave been perpetrated in the past, and this rule is intended to preventsuch imposition explanation of rule 6. Unwarranted therapeutic claimstherapeutic questions -- this rule insists that the claims ofmanufacturers or agents concerning the therapeutic properties of theirproducts must be compatible with demonstrable facts manufacturerswill be held responsible for all statements made or quoted in theiradvertising “literature” regarding their products recognizing theexistence of honest differences of opinion on thesis therapeuticquestions, the council desires to be liberal in the application ofthis rule it is natural that a manufacturer should be writingial towardhis own product, and a moderate degree of emphasis in advertising maynot be objectionable the council, however, will not admit claims whichare neither in harmony with already accepted facts nor supported byacceptable evidence in doubtful paper the council considers thesequestions with the advice and cooperation of its staff of clinicalconsultants clinical evidence -- to be acceptable, the clinical evidence mustoffer objective data with such citation of authority as will enable thecouncil to confirm the facts and establish the scientific value of theconclusions drawn clinical data are worthless when the author is notcited the facts on which claims with regard to the value of a remedyare based must have been rendered accessible for investigation andconfirmation by disinterested observers, either through publication orthrough the records of a hospital or other institution explanation of rule 7. Poisonous substancespoisons -- for the information of the pharmacist or dispenser, and toenable him to safeguard the interests of the patient and the physician, all articles containing such potent agents as the poisonous alkaloidsand other organic substances and the salts of essay of the metals shouldhave the exact amount of these ingredients which is contained in theaverage adult dose stated on the label explanation of rule 8. Objectionable names“coined” names -- thesis of the abuses connected with proprietarymedicines arise from “coined” proprietary trade names such names willnot be recognized by the council unless in writingicular instances thecouncil shall deem their use to be in the interest of public welfare in every such exception the burden of proof, both for establishing andfor continuing the exception, lies with those who market the product proprietary “trade” names when permitted -- in consideration ofthe benefits which may come from the discovery of a therapeuticagent, the council concedes to the person or firm which, by right ofdiscovery, controls such a product the right to name it the councilwill offer no opposition to an arbitrary name for such a new product, provided it is not misleading, therapeutically suggestive, or otherwisesubversive of scientific pharmacy and therapeutics if the discoverythat a previously known substance has therapeutic value is deemed ofsufficient importance, the council may recognize a name for such asubstance if the name is applied by the person who makes the discovery;or, with the consent of the discoverer or in the absence of any proteston his writing, the council may recognize a name applied by the firm whichfirst makes such a product available to physicians in the interestof rational drug therapy, the council recommends that trade names becoined so as to indicate the potent element or constituent scientific names -- when the proprietary or trade name for an articleis considered insufficiently descriptive of its chemical compositionor pharmaceutical character, the council may require as a conditionfor the acceptance of such articles that a descriptive scientificname satisfactory to the council appear on the labels, circularsand advertisements for such an article for all definite chemicalsubstances it is required that the scientific name be given prominenceon the labels, in circulars and advertisements proprietary names for unoriginal articles -- proprietary nameswill not be recognized for articles which are included in the u s pharmacopeia or national formulary or for unessential modificationsof such articles neither will proprietary names be recognized forsubstances or mixtures which are described in medical or pharmaceuticalpublications in the marketing of unoriginal articles, the legitimateinterests of the producer are fully served by identifying such productsby appending the name or initials of the manufacturer or agent, orby the use of a general brand mark no objection will be made by thecouncil to the use of such brand marks, provided that in no case shallsuch mark be used as a designation for an individual article for any product which, by reason of the absence or lapse of patentrights or for other reasons, is open to manufacture by more than onefirm, the council reserves the right to select a common name and toprovide standards of identity, purity and strength, and then willaccept such article only if it is marketed under the title adopted asthe n n r name or the name under which such article was introduced to which may be appended the firm identifying mark n n r to u s p -- when an article which has been accepted fornew and nonofficial remedies is admitted to the u s pharmacopeiaor national formulary, it will be omitted from new and nonofficialremedies one year after such standardization if the name of sucharticle is used in these standards either as the main title for theproduct or as a synonym if the name under which the article isdescribed in new and nonofficial remedies is not used in these books ofstandards, the proprietary preparation will be retained provided theofficial name is given prominence on the labels and in the circularsand advertisements of such article when the council adopts a commonname for an article that has been admitted under another name, itwill be continued under the older name only on condition that thecouncil name be given prominence on the label and in the circulars andadvertisements for such article pharmaceutical preparations and mixtures -- these, with rareexceptions, are not original in composition and there is seldothesis reason why they should be endowed with arbitrary names on thecontrary, it is important that the prescriber should be remindedconstantly of their potent ingredients therapeutically suggestive names -- articles bearing therapeuticallysuggestive names will not be accepted for new and nonofficial remedies, first, because they are likely to lead physicians into prescribingnames instead of remedies, and second, because they tend to encourageunwarranted self-medication by the laity even if the name is atfirst apparently meaningless to the public, its meaning will soon beunderstood because patients soon learn the technical names applied totheir diseases and symptoms the prohibition against therapeuticallysuggestive names is not applied to serums, vaccines and antitoxins, because the accepted nomenclature of the specific organisms used intheir preparation makes this unavoidable and because self-medicationwith them is improbable explanation of rule 9. Patents, trademarks, copyrights, etc protection -- this information is important as a means of determiningthe legal status of medicinal articles and as an aid to their readyrecognition in current publications explanation of rule 10. Unscientific and useless articlesunscientific compounds -- the use of articles which are unessentialmodifications of official or established nonproprietary articles isunscientific and serves no useful purpose the council will not acceptproducts which are scientifically unsound and which, therefore, mustbe considered useless or inimical to the best interest of the medicalprofession and the public this class includes compounds or mixturescontaining an excessive number of active ingredients.

  • quality writing services
  • examples of essay
  • write my thesis thesis
  • sample reflective essay
  • rhetoric essay
  • new act essay
  • sat sample essay
  • finance assignment help
  • buy a business plan for a daycare center
  • algebra homework help online
  • i pay and you write my thisis
  • research essay
  • uc essay prompts 2016-17
  • homework help websites high school
  • pay to write a research paper
  • help on essay writing
  • customer writing
  • term papers writers
  • college essay prompt
  • writing website
  • essay help websites

Let there be a good fire inthe chamber, and stir not out of the chamber till the purge have doneworking, or not till next day lastly, take sweating medicines when you are in bed, covered warm, andin the time of your sweating drink posset-drink as hot as you can ifyou sweat for a fever, boil sorrel and red sage in your posset-drink, sweat an hour or longer if your strength will permit, then the chamberbeing kept very warm shift yourself all but your head, about which the cap which you sweat in being still kept on wrap a napkin veryhot, to repel the vapours back i confess these, or thesis of these directions may be found in one placeof the book or other, and i delight as little to write tautology asanother, but considering it might make for the public good, i insertedthem in this place. If, notwithstanding, any will be so mad as to dothemselves a mischief, the fault is not mine roots acanths, brancæ ursinæ of bearsbreech, or brankursine, it is meanlyhot and dry, helps aches and numness of the joints, and is of a bindingquality, good for wounds and broken bones dioscorides saith, theyare profitable for ruptures, or such as are bursten, or burnt withfire, a dram of the root in powder being taken in the morning fasting, in a decoction made with the same root and water acori, veri, perigrini, vulgaris, &c see calamus aromaticus ishall not speak concerning the several sorts of it, one of which iswater-flag, or flower-de-luce, which is hot and dry in the seconddegree, binds, strengthens, stops fluxes of the belly, and immoderateflowing of the menses, a dram being taken in red wine every morning allium garlic it is hot and dry in the fourth degree, breedscorrupt blood, yet is an enemy to all poisons, and such as are bittenby cold venomous beasts, viz adders, toads, spiders, &c it provokesurine, and expels wind alcannæ of privet see the leaves althææ of marsh mallows, are meanly hot, of a digesting, softeningnature, ease pains, help bloody fluxes, the stone, and gravel. Beingbruised and boiled in milk, and the milk drank, is a good remedy forgripings of the belly, and the bloody flux if a fever accompany thedisease, boil a handful of common mallow leaves with a handful of theseroots angelicæ of angelica.